+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Leukapheresis - Global Strategic Business Report

  • PDF Icon

    Report

  • 179 Pages
  • April 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4845815
The global market for Leukapheresis was valued at US$96.0 Million in 2024 and is projected to reach US$143.7 Million by 2030, growing at a CAGR of 7.0% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Leukapheresis market.

Global Leukapheresis Market - Key Trends & Drivers Summarized

What Is Leukapheresis and Why Is It Gaining Importance in Medical Treatments?

Leukapheresis is a medical procedure that involves the selective removal of white blood cells (leukocytes) from the blood, which is increasingly being used in the treatment of various diseases, including leukemia, multiple myeloma, and autoimmune disorders. This procedure is gaining importance due to its critical role in both therapeutic and research settings. In therapeutic applications, leukapheresis is used to reduce high white blood cell counts, which can be dangerous in certain cancer patients. In research, it is employed to collect leukocytes for use in developing and testing new therapies, such as CAR-T cell therapy. As the demand for advanced treatment options grows, leukapheresis is becoming an essential tool in the medical field.

How Are Technological Advancements Impacting the Leukapheresis Market?

Technological advancements are playing a significant role in the growth of the leukapheresis market. The development of more efficient and automated apheresis machines has made the procedure safer, faster, and more comfortable for patients. These advancements are also enabling higher yields of leukocytes, which is particularly important for the success of therapies like CAR-T cell therapy. Additionally, innovations in leukapheresis techniques are reducing the risk of complications and improving patient outcomes. As technology continues to evolve, it is expected to further enhance the efficacy and accessibility of leukapheresis, driving its adoption in both clinical and research settings.

What Role Does Leukapheresis Play in the Advancement of Cancer Therapies?

Leukapheresis is playing a crucial role in the advancement of cancer therapies, particularly in the development of immunotherapies such as CAR-T cell therapy. In this process, leukapheresis is used to collect T cells from the patient’s blood, which are then genetically modified to target and destroy cancer cells. This personalized approach to cancer treatment has shown promising results, especially in patients with certain types of leukemia and lymphoma. The increasing success of these therapies is driving demand for leukapheresis, as it is a critical step in the treatment process. As more immunotherapies are developed and approved, the use of leukapheresis is expected to expand, making it a key component in the future of cancer treatment.

What Factors Are Driving the Growth of the Leukapheresis Market?

The growth in the leukapheresis market is driven by several factors, including the increasing prevalence of cancer and autoimmune diseases, advancements in apheresis technology, and the rising demand for personalized medicine. The growing adoption of immunotherapies, which rely on leukapheresis for the collection of immune cells, is also a significant driver. Additionally, the expansion of clinical trials and research activities focused on developing new treatments is boosting the demand for leukapheresis procedures. As the medical community continues to explore new therapeutic applications and improve existing ones, the leukapheresis market is expected to experience sustained growth, driven by its critical role in advancing modern medical treatments.

Report Scope

The report analyzes the Leukapheresis market, presented in terms of units. The analysis covers the key segments and geographic regions outlined below.

Segments: Offering (Devices, Disposables); Application (Research, Therapeutic); End-Use (Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies, Hospital & Transfusion Centers).

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Devices segment, which is expected to reach US$122.6 Million by 2030 with a CAGR of a 7.1%. The Disposables segment is also set to grow at 6.0% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $26.7 Million in 2024, and China, forecasted to grow at an impressive 6.5% CAGR to reach $22.2 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Leukapheresis Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Leukapheresis Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Leukapheresis Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Allcells LLC, Asahi Kasei Medical Co., Ltd., BioIVT, Caltag Medsystems Limited, Fresenius SE & Co. KGaA and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 12 companies featured in this Leukapheresis market report include:

  • Allcells LLC
  • Asahi Kasei Medical Co., Ltd.
  • BioIVT
  • Caltag Medsystems Limited
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • HemaCare Corporation
  • Key Biologics, LLC.
  • MacoPharma SA
  • Ppa Research Group, Inc.
  • Precision Medicine Group, Inc.
  • StemCell Technologies Inc.
  • StemExpress
  • Terumo BCT, Inc.
  • Zenbio, Inc.

Tariff Impact Analysis: Key Insights for 2025

Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.

The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.

What’s Included in This Edition:

  • Tariff-adjusted market forecasts by region and segment
  • Analysis of cost and supply chain implications by sourcing and trade exposure
  • Strategic insights into geographic shifts

Buyers receive a free July 2025 update with:

  • Finalized tariff impacts and new trade agreement effects
  • Updated projections reflecting global sourcing and cost shifts
  • Expanded country-specific coverage across the industry

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Leukapheresis - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Advancements in Apheresis Technology Propel Adoption of Leukapheresis in Therapeutic Applications
  • Shift Towards Personalized Medicine Expands Addressable Market for Leukapheresis
  • Rising Focus on Cell-Based Therapies and Immunotherapy Drives Adoption in Cancer Treatment
  • Rising Importance of Leukapheresis in Bone Marrow Transplantation Strengthens Demand
  • Growing Application of Leukapheresis in Stem Cell Collection Strengthens Market Demand
  • Technological Innovations in Leukapheresis Devices Enhance Efficiency and Patient Comfort
  • Expanding Use of Leukapheresis in Hematology and Oncology Generates New Opportunities
  • Push for High-Purity Cell Collection Fuels Demand in Clinical and Research Settings
  • Increasing Adoption of Leukapheresis in CAR-T Cell Therapy Accelerates Market Expansion
  • Technological Advancements in Automated and Continuous Flow Systems Expand Market Potential
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • Table 2: World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 3: World 15-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Therapeutic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • Table 5: World Historic Review for Therapeutic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 6: World 15-Year Perspective for Therapeutic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Blood Component Providers & Blood Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • Table 8: World Historic Review for Blood Component Providers & Blood Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 9: World 15-Year Perspective for Blood Component Providers & Blood Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • Table 11: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 12: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 13: World Leukapheresis Market Analysis of Annual Sales in US$ for Years 2015 through 2030
  • Table 14: World Recent Past, Current & Future Analysis for Leukapheresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • Table 15: World Historic Review for Leukapheresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 16: World 15-Year Perspective for Leukapheresis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • Table 18: World Historic Review for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 19: World 15-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • Table 21: World Historic Review for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 22: World 15-Year Perspective for Disposables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • Table 24: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 25: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 26: World Recent Past, Current & Future Analysis for Hospital & Transfusion Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • Table 27: World Historic Review for Hospital & Transfusion Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 28: World 15-Year Perspective for Hospital & Transfusion Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • Table 29: USA Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 30: USA Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 31: USA 15-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2015, 2025 & 2030
  • Table 32: USA Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 33: USA Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 34: USA 15-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2015, 2025 & 2030
  • Table 35: USA Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 36: USA Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 37: USA 15-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2015, 2025 & 2030
CANADA
  • Table 38: Canada Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 39: Canada Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 40: Canada 15-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2015, 2025 & 2030
  • Table 41: Canada Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 42: Canada Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 43: Canada 15-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2015, 2025 & 2030
  • Table 44: Canada Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 45: Canada Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 46: Canada 15-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2015, 2025 & 2030
JAPAN
  • Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • Table 47: Japan Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 48: Japan Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 49: Japan 15-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2015, 2025 & 2030
  • Table 50: Japan Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 51: Japan Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 52: Japan 15-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2015, 2025 & 2030
  • Table 53: Japan Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 54: Japan Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 55: Japan 15-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2015, 2025 & 2030
CHINA
  • Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • Table 56: China Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 57: China Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 58: China 15-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2015, 2025 & 2030
  • Table 59: China Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 60: China Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 61: China 15-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2015, 2025 & 2030
  • Table 62: China Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 63: China Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 64: China 15-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2015, 2025 & 2030
EUROPE
  • Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • Table 65: Europe Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 66: Europe Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 67: Europe 15-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2015, 2025 & 2030
  • Table 68: Europe Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 69: Europe Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 70: Europe 15-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2015, 2025 & 2030
  • Table 71: Europe Recent Past, Current & Future Analysis for Leukapheresis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • Table 72: Europe Historic Review for Leukapheresis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 73: Europe 15-Year Perspective for Leukapheresis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • Table 74: Europe Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 75: Europe Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 76: Europe 15-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2015, 2025 & 2030
FRANCE
  • Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • Table 77: France Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 78: France Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 79: France 15-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2015, 2025 & 2030
  • Table 80: France Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 81: France Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 82: France 15-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2015, 2025 & 2030
  • Table 83: France Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 84: France Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 85: France 15-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2015, 2025 & 2030
GERMANY
  • Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • Table 86: Germany Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 87: Germany Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 88: Germany 15-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2015, 2025 & 2030
  • Table 89: Germany Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 90: Germany Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 91: Germany 15-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2015, 2025 & 2030
  • Table 92: Germany Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 93: Germany Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 94: Germany 15-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2015, 2025 & 2030
ITALY
  • Table 95: Italy Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 96: Italy Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 97: Italy 15-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2015, 2025 & 2030
  • Table 98: Italy Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 99: Italy Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 100: Italy 15-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2015, 2025 & 2030
  • Table 101: Italy Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 102: Italy Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 103: Italy 15-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2015, 2025 & 2030
UNITED KINGDOM
  • Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • Table 104: UK Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 105: UK Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 106: UK 15-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2015, 2025 & 2030
  • Table 107: UK Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 108: UK Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 109: UK 15-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2015, 2025 & 2030
  • Table 110: UK Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 111: UK Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 112: UK 15-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2015, 2025 & 2030
REST OF EUROPE
  • Table 113: Rest of Europe Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 114: Rest of Europe Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 115: Rest of Europe 15-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2015, 2025 & 2030
  • Table 116: Rest of Europe Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 117: Rest of Europe Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 118: Rest of Europe 15-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2015, 2025 & 2030
  • Table 119: Rest of Europe Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 120: Rest of Europe Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 121: Rest of Europe 15-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2015, 2025 & 2030
ASIA-PACIFIC
  • Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • Table 122: Asia-Pacific Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 123: Asia-Pacific Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 124: Asia-Pacific 15-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2015, 2025 & 2030
  • Table 125: Asia-Pacific Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 126: Asia-Pacific Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 127: Asia-Pacific 15-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2015, 2025 & 2030
  • Table 128: Asia-Pacific Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • Table 129: Asia-Pacific Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • Table 130: Asia-Pacific 15-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2015, 2025 & 2030
REST OF WORLDIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Allcells LLC
  • Asahi Kasei Medical Co., Ltd.
  • BioIVT
  • Caltag Medsystems Limited
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • HemaCare Corporation
  • Key Biologics, LLC.
  • MacoPharma SA
  • Ppa Research Group, Inc.
  • Precision Medicine Group, Inc.
  • StemCell Technologies Inc.
  • StemExpress
  • Terumo BCT, Inc.
  • Zenbio, Inc.

Table Information